Samco Pharma Works Profile
Key Indicators
- Authorised Capital ₹ 1.85 M
- Paid Up Capital ₹ 1.82 M
- Company Age 45 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.00 Cr
- Revenue Growth -21.12%
- Profit Growth -133.10%
- Ebitda 45.29%
- Net Worth -0.52%
- Total Assets 33.02%
About Samco Pharma Works
Samco Pharma Works Pvt Ltd (SPWPL) is a Private Limited Indian Non-Government Company incorporated in India on 05 November 1979 and has a history of 45 years and three months. Its registered office is in Kolkata, West Bengal, India.
The Company is engaged in the Financial Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.85 M and a paid-up capital of Rs 1.82 M.
The company currently has active open charges totaling ₹1.00 Cr.
Krishna Daga and Mayank Daga serve as directors at the Company.
Company Details
-
Location
Kolkata, West Bengal, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24231WB1979PTC032331
-
Company No.
032331
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
05 Nov 1979
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Kolkata
Industry
Who are the key members and board of directors at Samco Pharma Works?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Krishna Daga
|
Whole-Time Director | 27-Feb-2009 | Current |
|
Mayank Daga
|
Whole-Time Director | 04-Apr-2019 | Current |
Financial Performance of Samco Pharma Works.
Samco Pharma Works Pvt Ltd, for the financial year ended 2023, experienced significant reduction in revenue, with a 21.12% decrease. The company also saw a substantial fall in profitability, with a 133.1% decrease in profit. The company's net worth dipped by a decrease of 0.52%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Samco Pharma Works?
In 2023, Samco Pharma Works had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹10.00 M
₹0
Charges Breakdown by Lending Institutions
- Others : 1.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Jan 2022 | Others | ₹1.00 Cr | Open |
How Many Employees Work at Samco Pharma Works?
Unlock and access historical data on people associated with Samco Pharma Works, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Samco Pharma Works, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Samco Pharma Works's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
